Katie Ellias

Board Observer at Seraxis - Germantown, MD, US

Katie Ellias's Contact Details
HQ
N/A
Location
316 Huntington Avenue,Boston,Massachusetts,02115,United States
Company
Seraxis
Katie Ellias's Company Details
Seraxis logo, Seraxis contact details

Seraxis

Germantown, MD, US • 10 - 19 Employees
BioTech/Drugs

Seraxis is a privately owned biotechnology company. Our GMP lab is located in Germantown, Maryland, in the heart of the vibrant BioHealth Capital Region. Launched in early 2013, Seraxis used proprietary technologies to develop a cell replacement therapy, SR-01, that is more effective and safer than embryonic stem cell-derived therapies. Our highly pure insulin-producing cells are micro-encapsulated through a proprietary technology that enables the function of human pancreas cells in type-1 diabetes models without the need for immuno-suppression.Seraxis intends to bring SR-01 to the clinic in order to provide a cure for the devastating disease of diabetes.

Cell therapy Cell encapsulation Regenerative medicine Stem cells
Details about Seraxis
Frequently Asked Questions about Katie Ellias
Katie Ellias currently works for Seraxis.
Katie Ellias's role at Seraxis is Board Observer.
Katie Ellias's email address is ***@jdrf.org. To view Katie Ellias's full email address, please signup to ConnectPlex.
Katie Ellias works in the Research industry.
Katie Ellias's colleagues at Seraxis are William Rust, Sam Trible, Ian McWilliams, Laurie Rodman, Andrew Jacob, Carole Welsch, Sheryl Southard and others.
Katie Ellias's phone number is N/A
See more information about Katie Ellias